HHealthcare Read More Eli Lilly, NIH grants, Novartis, Regeneron: Readout NewsletterOctober 3, 2026 Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
TTechnology Read More BCLXL blockade rewires cell fate to overcome PARP inhibitor resistance in ovarian cancerSeptember 21, 2026 Kaufman, B. et al. Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation. J. Clin.…
MMedication Read More GLP-1s in children, Syntis Bio, Vera: Readout NewsletterSeptember 16, 2026 National Biotech Reporter Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways…
HHealthcare Read More AI hunts new uses for Phase 3 metabolic drugSeptember 5, 2026 THPharm already has a drug in late-stage trials. Now it’s using AI to work backwards and find out…
MMedication Read More Enveda makes ‘exercise pill’ that skips the treadmillAugust 21, 2026 Drug mimics a hormone you make when you push hard at the gym – early results suggest it…
MMedication Read More Amylyx endocrine drug succeeds in key study for low blood sugarAugust 18, 2026 Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
MMedication Read More Enveda weight loss maintenance pill mimics exercise in early testsAugust 18, 2026 If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
MMedication Read More From GLP-1 hormone to weight-loss drug: How semaglutide is made and why quality mattersAugust 11, 2026 What does it really take to recreate one of today’s most talked-about medicines? As semaglutide gains traction worldwide,…
MMedication Read More Eli Lilly to offer retatrutide access given earlier to just one patientAugust 4, 2026 Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
MMedication Read More Compounded GLP-1s: Why doctors worry and the FDA is cracking downJuly 23, 2026 So, are these copycat versions of the weight loss drugs safe? Poison control centers across the U.S. have…
AArtificial intelligence Read More How AI is supercharging drug developmentJuly 20, 2026 Illustration: Aïda Amer/Axios. Stock: Getty Images Artificial intelligence is dramatically speeding up drug development — and a proprietary…
AArtificial intelligence Read More Scientists’ Side Hustle? Using AI and Quantum Computing to Generate New PeptidesJuly 12, 2026 Scientists have successfully shown a quantum computer can improve the accuracy and reach of generative artificial intelligence drug…